ReShape Lifesciences (Formally known as EnteroMedics)
280 articles about ReShape Lifesciences (Formally known as EnteroMedics)
-
EnteroMedics Announces 40% Reduction in Workforce
10/29/2009
-
EnteroMedics Announces Third Quarter 2009 Financial Results
10/23/2009
-
EnteroMedics Obesity Treatment Device Not Effective; Shares Dip
10/5/2009
-
EnteroMedics Announces $4.9 Million Financing
10/5/2009
-
EnteroMedics Appoints Dan Cohen as Senior Vice President of Government Relations and Health Policy
9/25/2009
-
EnteroMedics to Present at the 29th Annual Canaccord Adams Global Growth Conference
8/5/2009
-
EnteroMedics is Added to the Russell 3000(R) Index
6/30/2009
-
EnteroMedics to Present at the Canaccord Adams Annual Diabetes and Obesity Conference
5/5/2009
-
EnteroMedics Reports First Quarter 2009 Financial Results
4/24/2009
-
EnteroMedics Receives CE Mark Certification for the Maestro System for Obesity Therapy
3/9/2009
-
EnteroMedics Inc. Elects Jon T. Tremmel to Board of Directors
1/29/2009
-
EnteroMedics Inc. Announces Eighteen-Month Excess Weight Loss Results from its VBLOC-RF2 Feasibility Study
1/12/2009
-
EnteroMedics Inc. to Present at the 27th Annual JP Morgan Healthcare Conference
1/6/2009
-
EnteroMedics Inc. Announces Reduction in Workforce
12/2/2008
-
EnteroMedics Inc. Announces $20 Million Debt Financing
11/24/2008
-
EnteroMedics Inc. Reports Third Quarter 2008 Financial Results
10/22/2008
-
EnteroMedics Inc. Release: Data On VBLOC™ Therapy in Diabetes and Hypertension Presented at IFSO 13th World Congress on Obesity Surgery
9/26/2008
-
EnteroMedics Inc. to Host Conference Call after Presentation at the IFSO 13th World Congress on Obesity Surgery
9/19/2008
-
EnteroMedics Inc. Announces Management Changes within the Clinical Department
9/18/2008
-
EnteroMedics Inc. Announce Vice President of Medical Affairs and Chief Medical Officer Resign
9/18/2008